Search

No relevant pages have been found.

No relevant news have been found: 2

Survival benefit of cetuximab for metastatic colorectal cancer

to KRAS mutation status in patients with metastatic colorectal cancer (mCRC), and found that the addition of Erbitux (cetuximab) to standard chemotherapy...

Research points to why some colorectal cancers recur after treatment

growth factor receptor (EGFR), metastatic colorectal cancer (mCRC), extracellular methylation,...

No centres with the requested content found.